Participation of Increased Circulating MAIT Cells in Lung Cancer: a Pilot Study

Overview

Journal J Cancer

Specialty Oncology

Date 2022 Apr 4

PMID 35371315

Authors

Qian Zhang

Pengli Li

Wenqin Zhou

Shu Fang

Jiong Wang

Affiliations

Soon will be listed here.

Abstract

Mucosal-associated invariant T (MAIT) cells are a subset of innate-like T cells that regulate the immune response via rapidly releasing inflammatory factors, including during progression of some tumors. However, the immunological role of MAIT cells is still unclear in lung cancer. We measured percentage, partial function, and clinical correlation of circulating MAIT cells from lung cancer patients through flow cytometry. Lung cancer patients displayed a high concentration of CD4, CD8, and activated CD38CD8MAIT cells, and a decrease of PD1 double negative (DN) MAIT cells in peripheral blood. Meanwhile, increased levels of interferon-γ, interleukin (IL)-6, and 8 were examined in the serum of lung cancer patients. Importantly, we discovered a statistically positive association between accumulation of CD38CD8MAIT cells and reduced progression-free survival of lung cancer patients. While preliminary, the altering frequency of MAIT cells might be involved in dysfunctional immune response in lung cancer.

Citing Articles

Role of the TME in immune checkpoint blockade resistance of non-small cell lung cancer.

Dai Y, Tian X, Ye X, Gong Y, Xu L, Jiao L Cancer Drug Resist. 2025; 7():52.

PMID: 39802954 PMC: 11724356. DOI: 10.20517/cdr.2024.166.

Expression pattern and prognostic significance of aldehyde dehydrogenase 2 in lung adenocarcinoma as a potential predictor of immunotherapy efficacy.

Baldari S, Antonini A, Di Rocco G, Toietta G Cancer Innov. 2024; 4(1):e149.

PMID: 39640071 PMC: 11620833. DOI: 10.1002/cai2.149.

Mucosal associated invariant T cells: Powerhouses of the lung.

Lopez-Rodriguez J, Barral P Immunol Lett. 2024; 269:106910.

PMID: 39128630 PMC: 11835791. DOI: 10.1016/j.imlet.2024.106910.

Human V 7.2-J 33 mucosal-associated invariant T cells in endometrial ectopic tissues tend to produce interferon-gamma: A new player in endometriosis etiology: A case-control study.

Moghaddam M, Zare F, Sandoghsaz R, Khalili A, Shams A Int J Reprod Biomed. 2024; 22(3):235-244.

PMID: 38868448 PMC: 11165224. DOI: 10.18502/ijrm.v22i3.16168.

CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy.

Qu J, Wu B, Chen L, Wen Z, Fang L, Zheng J J Exp Clin Cancer Res. 2024; 43(1):134.

PMID: 38698468 PMC: 11067263. DOI: 10.1186/s13046-024-03046-3.

References

Reantragoon R, Kjer-Nielsen L, Patel O, Chen Z, Illing P, Bhati M . Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor. J Exp Med. 2012; 209(4):761-74. PMC: 3328369. DOI: 10.1084/jem.20112095. View

Goldstraw P, Crowley J, Chansky K, Giroux D, Groome P, Rami-Porta R . The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007; 2(8):706-14. DOI: 10.1097/JTO.0b013e31812f3c1a. View

Liu L, Ge D, Ma L, Mei J, Liu S, Zhang Q . Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer. J Thorac Oncol. 2012; 7(7):1091-100. PMC: 3378786. DOI: 10.1097/JTO.0b013e3182542752. View

Park M, Yang A, Lee J, Kim S, Roe J, Park M . GALNT3 suppresses lung cancer by inhibiting myeloid-derived suppressor cell infiltration and angiogenesis in a TNFR and c-MET pathway-dependent manner. Cancer Lett. 2021; 521:294-307. DOI: 10.1016/j.canlet.2021.08.015. View

Wallington J, Williams A, Staples K, Wilkinson T . IL-12 and IL-7 synergize to control mucosal-associated invariant T-cell cytotoxic responses to bacterial infection. J Allergy Clin Immunol. 2017; 141(6):2182-2195.e6. DOI: 10.1016/j.jaci.2017.08.009. View

Shao C, Zhu C, Zhu Y, Hao J, Li Y, Hu H . Decrease of peripheral blood mucosal-associated invariant T cells and impaired serum Granzyme-B production in patients with gastric cancer. Cell Biosci. 2021; 11(1):12. PMC: 7796455. DOI: 10.1186/s13578-020-00518-9. View

Sawant A, Schafer C, Jin T, Zmijewski J, Tse H, Roth J . Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways. Cancer Res. 2013; 73(22):6609-20. PMC: 3854493. DOI: 10.1158/0008-5472.CAN-13-0987. View

Haeryfar S, Shaler C, Rudak P . Mucosa-associated invariant T cells in malignancies: a faithful friend or formidable foe?. Cancer Immunol Immunother. 2018; 67(12):1885-1896. PMC: 11028145. DOI: 10.1007/s00262-018-2132-1. View

Salou M, Legoux F, Lantz O . MAIT cell development in mice and humans. Mol Immunol. 2020; 130:31-36. DOI: 10.1016/j.molimm.2020.12.003. View

10.

Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A . The CD4CD8 MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8 MAIT cell pool. Proc Natl Acad Sci U S A. 2018; 115(49):E11513-E11522. PMC: 6298106. DOI: 10.1073/pnas.1812273115. View

11.

Melo A, OBrien A, Phelan J, Kennedy S, Wood N, Veerapen N . Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma. Front Immunol. 2019; 10:1580. PMC: 6635552. DOI: 10.3389/fimmu.2019.01580. View

12.

Gold M, Napier R, Lewinsohn D . MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis. Immunol Rev. 2015; 264(1):154-66. PMC: 4339229. DOI: 10.1111/imr.12271. View

13.

Marshall E, Ng K, Kung S, Conway E, Martinez V, Halvorsen E . Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis. Mol Cancer. 2016; 15(1):67. PMC: 5082389. DOI: 10.1186/s12943-016-0551-1. View

14.

Harriff M, Karamooz E, Burr A, Grant W, Canfield E, Sorensen M . Endosomal MR1 Trafficking Plays a Key Role in Presentation of Mycobacterium tuberculosis Ligands to MAIT Cells. PLoS Pathog. 2016; 12(3):e1005524. PMC: 4816560. DOI: 10.1371/journal.ppat.1005524. View

15.

Rudak P, Choi J, Haeryfar S . MAIT cell-mediated cytotoxicity: Roles in host defense and therapeutic potentials in infectious diseases and cancer. J Leukoc Biol. 2018; 104(3):473-486. DOI: 10.1002/JLB.4RI0118-023R. View

16.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

17.

Zhang Y, Fan Y, He W, Han Y, Bao H, Yang R . Persistent deficiency of mucosa-associated invariant T (MAIT) cells during alcohol-related liver disease. Cell Biosci. 2021; 11(1):148. PMC: 8320031. DOI: 10.1186/s13578-021-00664-8. View

18.

Emgard J, Bergsten H, McCormick J, Barrantes I, Skrede S, Sandberg J . MAIT Cells Are Major Contributors to the Cytokine Response in Group A Streptococcal Toxic Shock Syndrome. Proc Natl Acad Sci U S A. 2019; 116(51):25923-25931. PMC: 6926028. DOI: 10.1073/pnas.1910883116. View

19.

Gueguen P, Metoikidou C, Dupic T, Lawand M, Goudot C, Baulande S . Contribution of resident and circulating precursors to tumor-infiltrating CD8 T cell populations in lung cancer. Sci Immunol. 2021; 6(55). DOI: 10.1126/sciimmunol.abd5778. View

20.

van Wilgenburg B, Loh L, Chen Z, Pediongco T, Wang H, Shi M . MAIT cells contribute to protection against lethal influenza infection in vivo. Nat Commun. 2018; 9(1):4706. PMC: 6226485. DOI: 10.1038/s41467-018-07207-9. View